Delivery Order SPE2DB22D1106-SPE2DB25FERU1

Award Date 6/4/25
Potential Completion Date 6/26/25
Potential Value $9.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Lenvima 8 mg, with a ceiling value of $9,910.95 and a period of performance through May 29, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the prescription drug Lenvima. The contract has a firm fixed price, ceiling value of $19,821.90, and a period of performance through May 30, 2025. The award is not set aside and represents an open competition. As an Indefinite Delivery Contract (IDC) holder with DLA, AmerisourceBergen can fulfill a wide...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $18,559.58. The contract is for the supply of the pharmaceutical product Lenvima 14 mg daily dose, with a completion date of June 5, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
This is a $9,910.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the medication LENVIMA 14 MG DAILY DOSE 60S, with a period of performance through July 1, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a Delivery Order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,279.78, is for the supply of LENVIMA 14 MG DAILY DOSE 60S, a specialty medication. This Delivery Order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,910.95, is for the supply of the prescription medication Lenvima 10 mg with a performance period through May 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.95 firm fixed-price delivery order is for the supply of the medication Lenvima 14 mg, with a performance period extending to May 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lenvima 10 mg daily dose 30s, a prescription medication. The contract has a ceiling value of $9,910.95 and a period of performance through June 4, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a $9,910.95 firm fixed-price delivery order for the pharmaceutical product LENVIMA 14 MG DAILY DOSE 60S, with a completion date of June 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LENVIMA 10 MG DAILY DOSE 30S, a prescription medication, with a ceiling value of $9,910.95 and a period of performance through June 12, 2025. The contract is a firm fixed-price delivery order, which indicates the delivery of specific pharmaceutical products rather than broader...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FERU1
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lenvima 24 mg daily dose 90s, a prescription medication, with a ceiling value of $9,910.95. The contract is a Firm Fixed Price type and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is part of that larger IDC, allowing AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 10:03 AM